封面
市場調查報告書
商品編碼
2080379

支架市場:2026-2032年全球市場預測(依產品類型、材料、輸送方式、應用及最終用戶分類)

Stents Market by Product Type, Material, Mode of Delivery, Application, End User - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年,支架市場規模將成長至 253.3 億美元,複合年成長率為 7.75%。

主要市場統計數據
基準年 2025 150.1億美元
預計年份:2026年 161.1億美元
預測年份:2032年 253.3億美元
複合年成長率 (%) 7.75%

支架市場的發展主要受全球心血管疾病、周邊血管疾病、神經血管疾病和泌尿系統疾病負擔的驅動。世界衛生組織(WHO)將心血管疾病列為全球首要死因,每年估計造成1,790萬人死亡。這持續推高了經皮冠狀動脈介入治療、周邊動脈介入治療和其他微創治療的需求。

藥物釋放型支架、塗層支架、裸金屬支架、生物可吸收支架、頸動脈支架、輸尿管支架和顱內支架系統等產品持續發展,其核心在於三個可衡量的優先事項:提高血管通暢性、降低血管再阻塞和血栓症形成風險以及加快患者康復。推動產業發展的因素包括臨床指引的採納、醫院導管檢查室容量的提升、健保報銷政策的調整、材料科學的進步,以及美國FDA和歐洲醫療設備法規(MDR)等監管機構日益嚴格的證據要求。

支架產業的變革

支架產業正從以器械為中心的競爭轉向以實證醫學為基礎、整合手術流程的治療模式。與不含藥物的塗層支架相比,新一代藥物釋放型支架幾乎完全取代了它們在冠狀動脈介入治療中的應用,隨機對照試驗和臨床指南的證據均支持其在許多患者群體中降低了重組率。同時,周邊血管支架和塗層支架的市場也在不斷擴大,尤其是在老年人和糖尿病患者中周邊動脈疾病診斷數量不斷增加的情況下。

人工智慧(AI)的累積影響

人工智慧 (AI) 正開始影響支架價值鏈的各個環節,從診斷到上市後監測。在臨床實務中,AI 驅動的影像分析能夠評估冠狀動脈鈣化、量化病灶、測量血管尺寸,並自動解讀來自血管造影術、CT血管攝影檢查、血管內超音波和光學同調斷層掃描(OCT) 的資料集。這些功能至關重要,因為不恰當的支架尺寸選擇或不完整的病變評估會增加血管再阻塞、支架不匹配或再次介入治療的風險。

關於支架的關鍵區域見解

由於中國、印度、日本、韓國、澳洲和東南亞等地區擁有龐大的病患群體,且醫療保險覆蓋範圍不斷擴大,介入性心臟病學能力也在不斷提升,亞太地區是支架市場的重中之重。此外,該地區糖尿病和高血壓的快速成長也對其市場產生影響,因為這兩種疾病都是冠狀動脈和周邊動脈疾病的公認危險因子。北美市場雖然較成熟,但創新依然活躍。這得歸功於先進的導管檢查室基礎設施、獲得FDA已通過核准的技術、積極的臨床試驗以及藥物釋放型支架、塗層支架和周邊血管支架的高市場滲透率。

集團在主要經濟領域的主要觀點

東協地區的需求成長主要受糖尿病和高血壓發病率上升、都市化以及新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國心臟護理網路發展等因素驅動。海灣合作理事會(GCC)成員國心血管疾病風險因素高、公共醫療費用支出龐大,且主要醫院傾向採用國際檢驗的技術。歐盟醫療設備法規(MDR)在安全性、可追溯性、臨床證據和上市後監管方面持續保持領先地位,因此,冠狀動脈支架、周邊動脈支架、頸動脈支架和輸尿管支架的供應商必須做好監管準備。

主要國家支架需求趨勢

美國在先進冠狀動脈介入治療、臨床試驗以及FDA監管的醫療設備創新方面處於主導,而加拿大則強調循證報銷和各省之間的公平獲取。墨西哥和巴西是重要的拉丁美洲市場,都市區心臟中心正在推動PCI的普及,但公共部門採購、報銷時間和價格可負擔性等因素正在影響產品組合。在歐洲,英國、德國、法國、義大利和西班牙受益於成熟的循環系統醫療保健網路、統一的國家指南以及藥物釋放型支架的廣泛應用,其中德國尤其在介入手術和醫療技術應用方面繼續發揮重要作用。

為行業領導者提供的實用建議

產業領導者應優先考慮從真實世界患者群體中獲取證據,包括糖尿病、慢性腎臟病、鈣化病變、小血管、分叉病變和複雜周邊動脈疾病患者。差異化應著重於可衡量的結果,例如目標病變失敗、支架血栓症、血管再阻塞、輸送、手術效率、與橈動脈入路的兼容性以及長期安全性。

調查方法

本執行摘要基於系統性的二次研究方法,使用了經過驗證的公共資源,包括世界衛生組織疾病負擔數據、美國FDA和歐洲醫療設備監管調查方法的監管指南、主要循環系統學會的臨床指南、關於藥物釋放型檢驗和PCI的同行評審資訊來源以及公開可用的醫療保健基礎設施指標。

結論

隨著心血管疾病持續對全球醫療系統帶來沉重負擔,支架市場在臨床上仍然至關重要。藥物釋放型支架、塗層支架、先進成像技術、人工智慧輔助決策以及監管機構對安全性和長期療效證據日益成長的要求,市場需求也在不斷變化。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣,2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:人工智慧的累積影響,2026年

第7章:支架市場:依產品類型分類

  • 冠狀動脈支架
  • 胃腸道支架
  • 神經血管支架
    • 顱外頸動脈支架
    • 顱內支架
  • 末梢用支架
    • 頸動脈支架
    • 股動脈支架
    • 髂動脈支架
    • 腎動脈支架
  • 泌尿系統支架
    • 攝護腺支架
    • 輸尿管支架

第8章:支架市場:依材料分類

  • 金屬支架
    • 鈷鉻合金
    • 鎳鈦諾
    • 鉑金鉻
    • 防鏽的
  • 聚合物支架
    • 可生物分解聚合物
    • 不可生物分解聚合物

第9章:支架市場:依輸送方式分類

  • 球囊擴張支架
  • 自膨式支架

第10章:支架市場:依應用領域分類

  • 心血管疾病
  • 胃腸道阻塞
  • 神經血管疾病
  • 癌症相關應用
  • 周邊動脈疾病(PAD)
  • 泌尿系統疾病

第11章:支架市場:依最終用戶分類

  • 門診手術中心(ASC)
  • 循環系統中心
  • 醫院
  • 專科診所

第12章:支架市場:依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章:支架市場:依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 支架市場:依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年

第16章:公司簡介

  • Abbott Laboratories
  • B. Braun AG
  • Becton, Dickinson and Company
  • Biosensors International Group, Ltd.
  • Boston Scientific Corporation
  • Concept Medical
  • Cook Medical LLC
  • Cordis Corporation
  • Elixir Medical Corporation
  • ELLA-CS, sro
  • Endologix LLC
  • Glaukos Corporation
  • Hexacath
  • InspireMD, Inc.
  • Integer Holdings Corporation
  • Lepu Medical Technology Co., Ltd
  • Medinol Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd
  • MicroPort Scientific Corporation
  • OrbusNeich Medical Group Holdings Limited
  • Relisys Medical Devices Limited
  • Sahajanand Medical Technologies Pvt. Ltd
  • Terumo Corporation
  • Translumina Therapeutics
  • WL Gore & Associates, Inc.
Product Code: MRR-434CCDA04EF3

The Stents Market is projected to grow by USD 25.33 billion at a CAGR of 7.75% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.01 billion
Estimated Year [2026] USD 16.11 billion
Forecast Year [2032] USD 25.33 billion
CAGR (%) 7.75%

The stents market is anchored by the global burden of cardiovascular, peripheral vascular, neurovascular, and urological disease. The World Health Organization identifies cardiovascular diseases as the leading cause of death worldwide, responsible for an estimated 17.9 million deaths annually, which sustains procedural demand for percutaneous coronary intervention, peripheral artery intervention, and other minimally invasive therapies.

Drug-eluting stents, covered stents, bare-metal stents, bioresorbable scaffolds, carotid stents, ureteral stents, and intracranial stent systems continue to evolve around three measurable priorities: improving vessel patency, reducing restenosis and thrombosis risk, and enabling faster patient recovery. Industry momentum is shaped by clinical guideline adoption, hospital catheterization laboratory capacity, reimbursement policy, material science, and stronger evidence requirements from regulators such as the U.S. FDA and European authorities under the Medical Device Regulation.

Transformative Shifts in the Stents Landscape

The stents landscape is shifting from device-centric competition toward evidence-led, procedure-integrated care. New-generation drug-eluting stents have largely displaced bare-metal stents in coronary intervention because randomized evidence and clinical guidelines support lower repeat revascularization rates in many patient groups. At the same time, peripheral vascular stents and covered stents are expanding with the rising diagnosis of peripheral artery disease, particularly among aging and diabetic populations.

Transformative change is also coming from imaging-guided intervention, radial access, complex lesion treatment, and device miniaturization. Intravascular ultrasound, optical coherence tomography, and fractional flow reserve are improving lesion assessment and stent optimization. Manufacturers are increasingly differentiating through polymer durability, drug-release profiles, alloy design, deliverability, radiopacity, and compatibility with complex anatomies rather than through platform claims alone.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence the stents value chain from diagnosis to post-market surveillance. In clinical settings, AI-enabled image analysis can support coronary calcium assessment, lesion quantification, vessel sizing, and automated interpretation of angiography, CT angiography, intravascular ultrasound, and optical coherence tomography datasets. These capabilities are relevant because inappropriate sizing or incomplete lesion assessment can increase the risk of restenosis, malapposition, or repeat intervention.

AI is also strengthening manufacturing quality control, supply planning, inventory allocation, and adverse-event signal detection across regulated medical device ecosystems. However, adoption depends on validated algorithms, diverse training datasets, cybersecurity controls, explainability, and regulatory-grade evidence. Industry leaders that pair AI with prospective clinical validation and human-in-the-loop workflows are better positioned to improve procedural consistency without overstating autonomous decision-making.

Key Regional Insights for Stents

Asia-Pacific is a high-priority region for stents because of large patient pools, rising health insurance coverage, and expanding interventional cardiology capacity in China, India, Japan, South Korea, Australia, and Southeast Asia. The region is also influenced by the rapid increase in diabetes and hypertension, both recognized risk factors for coronary artery disease and peripheral artery disease. North America remains mature but innovation-intensive, supported by advanced catheterization laboratory infrastructure, FDA-cleared technologies, strong clinical trial activity, and high use of drug-eluting stents, covered stents, and peripheral vascular stents.

Latin America is advancing through public-private hospital investment and broader access to percutaneous coronary intervention in Brazil, Mexico, and major urban centers, though affordability, public reimbursement, and specialist distribution continue to shape access. Europe benefits from guideline-driven care, centralized procurement, established interventional cardiology networks, and MDR-led safety and post-market surveillance expectations. The Middle East is investing in tertiary cardiac centers, digital hospitals, and medical tourism hubs, while Africa presents long-term opportunity as cardiovascular diagnosis improves; however, access to interventional procedures remains uneven due to infrastructure gaps, specialist availability, and payer limitations.

Key Group Insights Across Major Economic Blocs

ASEAN demand is influenced by rising diabetes, hypertension, urbanization, and the buildout of cardiac care networks across Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The GCC is characterized by high cardiovascular risk factors, significant public healthcare spending, and a preference for internationally validated technologies in leading hospitals. The European Union remains a benchmark for safety, traceability, clinical evidence, and post-market surveillance under the Medical Device Regulation, making regulatory readiness essential for coronary, peripheral, carotid, and ureteral stent suppliers.

BRICS countries combine large disease burdens with heterogeneous reimbursement, procurement, and domestic manufacturing systems, creating demand for both premium and cost-effective stent platforms. G7 markets drive clinical evidence generation, next-generation drug-eluting stent adoption, imaging-guided PCI, and long-term outcomes research. NATO countries are increasingly relevant to supply-chain resilience because medical device availability is viewed through healthcare security, logistics redundancy, sterile manufacturing continuity, and critical infrastructure preparedness.

Key Country Insights for Stents Demand

The United States leads in advanced coronary intervention, clinical trial activity, and FDA-regulated device innovation, while Canada emphasizes evidence-based reimbursement and equitable provincial access. Mexico and Brazil are important Latin American markets where urban cardiac centers support PCI adoption, although public-sector purchasing, reimbursement timing, and affordability shape the product mix. In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from mature cardiology networks, national guideline alignment, and broad access to drug-eluting stents, with Germany maintaining a strong role in interventional procedure volume and medical technology adoption.

Russia presents demand for cardiovascular intervention but faces procurement and supply-chain complexity. China is scaling domestic stent manufacturing and expanding PCI access through hospital network development, while India is driven by a high coronary disease burden, price-sensitive procurement, and increasing access to interventional cardiology outside major metropolitan centers. Japan is distinguished by advanced imaging use, strict quality expectations, and strong procedural standardization. Australia and South Korea combine modern hospital infrastructure, reimbursement discipline, and high adoption of clinically validated stent technologies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence generation across real-world populations, including patients with diabetes, chronic kidney disease, calcified lesions, small vessels, bifurcation disease, and complex peripheral artery disease. Differentiation should focus on measurable outcomes such as target lesion failure, stent thrombosis, restenosis, deliverability, procedural efficiency, radial access compatibility, and long-term safety.

Organizations should also strengthen AI-enabled imaging partnerships, invest in resilient regional supply chains, and design market access strategies by reimbursement tier. In emerging markets, value-engineered platforms, physician training, clinical education, and financing partnerships can accelerate responsible adoption. In mature markets, clinical evidence, interoperability with imaging systems, post-market data transparency, and compliance with evolving medical device regulations will be decisive.

Research Methodology

This executive summary is developed from a structured secondary research methodology using verified public sources, including WHO disease burden data, regulatory guidance from the U.S. FDA and European medical device authorities, clinical guideline positions from major cardiology societies, peer-reviewed evidence on drug-eluting stents and PCI, and publicly available healthcare infrastructure indicators.

The analysis applies cross-validation across epidemiology, reimbursement, regulatory, clinical, and technology adoption signals. Interpretations avoid unsupported projections and emphasize observable drivers: disease prevalence, procedure access, device regulation, procurement behavior, clinical outcomes, physician adoption, and innovation readiness.

Conclusion

The stents market remains clinically essential as cardiovascular and vascular disease continue to pressure healthcare systems worldwide. Demand is being reshaped by drug-eluting platforms, covered stents, advanced imaging, AI-assisted decision support, and stronger regulatory expectations for safety and long-term evidence.

Sustainable growth will favor organizations that combine proven device performance with data transparency, physician training, supply reliability, and region-specific market access strategies. The next phase of competition will be defined not only by better stent design, but also by stronger integration into evidence-based, minimally invasive care pathways.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Stents Market, by Product Type

  • 7.1. Coronary Stents
  • 7.2. Gastrointestinal Stents
  • 7.3. Neurovascular Stents
    • 7.3.1. Extracranial Carotid Artery Stents
    • 7.3.2. Intracranial Stents
  • 7.4. Peripheral Stents
    • 7.4.1. Carotid Artery Stents
    • 7.4.2. Femoral Artery Stents
    • 7.4.3. Iliac Artery Stents
    • 7.4.4. Renal Artery Stents
  • 7.5. Urological Stents
    • 7.5.1. Prostatic Stents
    • 7.5.2. Ureteral Stents

8. Stents Market, by Material

  • 8.1. Metallic Stents
    • 8.1.1. Cobalt Chromium
    • 8.1.2. Nitinol
    • 8.1.3. Platinum Chromium
    • 8.1.4. Stainless Steel
  • 8.2. Polymeric Stents
    • 8.2.1. Biodegradable Polymers
    • 8.2.2. Non-biodegradable Polymers

9. Stents Market, by Mode of Delivery

  • 9.1. Balloon-Expandable Stents
  • 9.2. Self-Expanding Stents

10. Stents Market, by Application

  • 10.1. Cardiovascular Diseases
  • 10.2. Gastrointestinal Obstructions
  • 10.3. Neurovascular Conditions
  • 10.4. Oncology-Related Applications
  • 10.5. Peripheral Artery Disease (PAD)
  • 10.6. Urological Disorders

11. Stents Market, by End User

  • 11.1. Ambulatory Surgical Centers (ASCs)
  • 11.2. Cardiology Centers
  • 11.3. Hospitals
  • 11.4. Specialty Clinics

12. Stents Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Stents Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Stents Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. B. Braun AG
  • 16.3. Becton, Dickinson and Company
  • 16.4. Biosensors International Group, Ltd.
  • 16.5. Boston Scientific Corporation
  • 16.6. Concept Medical
  • 16.7. Cook Medical LLC
  • 16.8. Cordis Corporation
  • 16.9. Elixir Medical Corporation
  • 16.10. ELLA - CS, s.r.o.
  • 16.11. Endologix LLC
  • 16.12. Glaukos Corporation
  • 16.13. Hexacath
  • 16.14. InspireMD, Inc.
  • 16.15. Integer Holdings Corporation
  • 16.16. Lepu Medical Technology Co., Ltd
  • 16.17. Medinol Ltd.
  • 16.18. Medtronic plc
  • 16.19. Meril Life Sciences Pvt. Ltd
  • 16.20. MicroPort Scientific Corporation
  • 16.21. OrbusNeich Medical Group Holdings Limited
  • 16.22. Relisys Medical Devices Limited
  • 16.23. Sahajanand Medical Technologies Pvt. Ltd
  • 16.24. Terumo Corporation
  • 16.25. Translumina Therapeutics
  • 16.26. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL STENTS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL STENTS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL STENTS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL STENTS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL STENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL STENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL STENTS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL STENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL STENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL STENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL STENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL STENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CORONARY STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACRANIAL CAROTID ARTERY STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACRANIAL CAROTID ARTERY STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACRANIAL CAROTID ARTERY STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CAROTID ARTERY STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CAROTID ARTERY STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CAROTID ARTERY STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FEMORAL ARTERY STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FEMORAL ARTERY STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FEMORAL ARTERY STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ILIAC ARTERY STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ILIAC ARTERY STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ILIAC ARTERY STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RENAL ARTERY STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RENAL ARTERY STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RENAL ARTERY STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL UROLOGICAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL UROLOGICAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL UROLOGICAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PROSTATIC STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PROSTATIC STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PROSTATIC STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL URETERAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL URETERAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL URETERAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL METALLIC STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL METALLIC STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL METALLIC STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COBALT CHROMIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COBALT CHROMIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COBALT CHROMIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NITINOL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NITINOL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NITINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PLATINUM CHROMIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PLATINUM CHROMIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PLATINUM CHROMIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STAINLESS STEEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STAINLESS STEEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL STAINLESS STEEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL POLYMERIC STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL POLYMERIC STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL POLYMERIC STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIODEGRADABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NON-BIODEGRADABLE POLYMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NON-BIODEGRADABLE POLYMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NON-BIODEGRADABLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GASTROINTESTINAL OBSTRUCTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROINTESTINAL OBSTRUCTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GASTROINTESTINAL OBSTRUCTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROVASCULAR CONDITIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEUROVASCULAR CONDITIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROVASCULAR CONDITIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ONCOLOGY-RELATED APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ONCOLOGY-RELATED APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ONCOLOGY-RELATED APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL ARTERY DISEASE (PAD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL ARTERY DISEASE (PAD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERAL ARTERY DISEASE (PAD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL UROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL UROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL UROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CARDIOLOGY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CARDIOLOGY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CARDIOLOGY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. GCC STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 188. GCC STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 189. GCC STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 190. GCC STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. GCC STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 192. GCC STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 193. GCC STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 194. GCC STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. GCC STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. G7 STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 222. G7 STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 223. G7 STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. G7 STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 225. G7 STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 226. G7 STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 227. G7 STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. G7 STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. NATO STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. NATO STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 233. NATO STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 234. NATO STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 235. NATO STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 236. NATO STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 237. NATO STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 238. NATO STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. NATO STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. CANADA STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 255. CANADA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 256. CANADA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 257. CANADA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 258. CANADA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 259. CANADA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 260. CANADA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 261. CANADA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. CANADA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. MEXICO STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. MEXICO STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. MEXICO STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 266. MEXICO STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 267. MEXICO STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 268. MEXICO STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 269. MEXICO STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 270. MEXICO STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 271. MEXICO STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 272. MEXICO STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. MEXICO STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. BRAZIL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. BRAZIL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. BRAZIL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 277. BRAZIL STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 278. BRAZIL STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 279. BRAZIL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 280. BRAZIL STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 281. BRAZIL STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 282. BRAZIL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 283. BRAZIL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. BRAZIL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED KINGDOM STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED KINGDOM STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED KINGDOM STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED KINGDOM STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED KINGDOM STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED KINGDOM STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED KINGDOM STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED KINGDOM STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED KINGDOM STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED KINGDOM STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. GERMANY STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. GERMANY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. GERMANY STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 299. GERMANY STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 300. GERMANY STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 301. GERMANY STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 302. GERMANY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 303. GERMANY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 304. GERMANY STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 305. GERMANY STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. GERMANY STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 307. FRANCE STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. FRANCE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. FRANCE STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 310. FRANCE STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 311. FRANCE STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 312. FRANCE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 313. FRANCE STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 314. FRANCE STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 315. FRANCE STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 316. FRANCE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 317. FRANCE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 318. RUSSIA STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 319. RUSSIA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. RUSSIA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 321. RUSSIA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 322. RUSSIA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 323. RUSSIA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 324. RUSSIA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 325. RUSSIA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 326. RUSSIA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 327. RUSSIA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 328. RUSSIA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 329. ITALY STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 330. ITALY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. ITALY STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 332. ITALY STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 333. ITALY STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 334. ITALY STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 335. ITALY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 336. ITALY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 337. ITALY STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 338. ITALY STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 339. ITALY STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 340. SPAIN STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 341. SPAIN STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. SPAIN STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 343. SPAIN STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 344. SPAIN STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 345. SPAIN STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 346. SPAIN STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 347. SPAIN STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 348. SPAIN STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 349. SPAIN STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 350. SPAIN STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 351. CHINA STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 352. CHINA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 353. CHINA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 354. CHINA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 355. CHINA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 356. CHINA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 357. CHINA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 358. CHINA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 359. CHINA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 360. CHINA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 361. CHINA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 362. INDIA STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 363. INDIA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 364. INDIA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 365. INDIA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 366. INDIA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 367. INDIA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 368. INDIA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 369. INDIA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 370. INDIA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 371. INDIA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 372. INDIA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 373. JAPAN STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 374. JAPAN STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 375. JAPAN STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 376. JAPAN STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 377. JAPAN STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 378. JAPAN STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 379. JAPAN STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 380. JAPAN STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 381. JAPAN STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 382. JAPAN STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 383. JAPAN STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 384. AUSTRALIA STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 385. AUSTRALIA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 386. AUSTRALIA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 387. AUSTRALIA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 388. AUSTRALIA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 389. AUSTRALIA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 390. AUSTRALIA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 391. AUSTRALIA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 392. AUSTRALIA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 393. AUSTRALIA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 394. AUSTRALIA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 395. SOUTH KOREA STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 396. SOUTH KOREA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 397. SOUTH KOREA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 398. SOUTH KOREA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 399. SOUTH KOREA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 400. SOUTH KOREA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MI